This page is part of the FHIR Specification (v3.5.0: R4 Ballot #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Ballot Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw XML (canonical form + also see XML Format Specification)
Oral Chemotherapy Order - Myleran - completed - with reasonCode (id = "medrx0306")
<?xml version="1.0" encoding="UTF-8"?> <MedicationRequest xmlns="http://hl7.org/fhir"> <id value="medrx0306"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative with Details</b> </p> <p> <b> id</b> : medrx0306</p> <p> <b> contained</b> : </p> <p> <b> identifier</b> : 12345689 (OFFICIAL)</p> <p> <b> status</b> : active</p> <p> <b> intent</b> : order</p> <p> <b> medication</b> : Myleran 2mg tablet. Generated Summary: id: med0304; Myleran 2mg tablet, film coated <span> (Details : {http://hl7.org/fhir/sid/ndc code '76388-713-25' = '76388-713-25', given as 'Myleran 2mg tablet, film coated'})</span> </p> <p> <b> subject</b> : <a> Donald Duck</a> </p> <p> <b> authoredOn</b> : 15/01/2015</p> <p> <b> requester</b> : <a> Patrick Pump</a> </p> <p> <b> reasonCode</b> : Chronic myeloid Leukemia (disorder) <span> (Details : {SNOMED CT code '92818009' = 'Chronic myeloid leukemia', given as 'Chronic myeloid Leukemia (disorder)'})</span> </p> <p> <b> dosageInstruction</b> : </p> </div> </text> <contained> <Medication> <id value="med0304"/> <code> <coding> <system value="http://hl7.org/fhir/sid/ndc"/> <code value="76388-713-25"/> <display value="Myleran 2mg tablet, film coated"/> </coding> </code> </Medication> </contained> <identifier> <use value="official"/> <system value="http://www.bmc.nl/portal/prescriptions"/> <value value="12345689"/> </identifier> <status value="active"/> <intent value="order"> </intent> <medicationReference> <reference value="#med0304"/> <display value="Myleran 2mg tablet"/> </medicationReference> <subject> <!-- Linked to the resource patient who needs the medication --> <reference value="Patient/pat1"/> <display value="Donald Duck"/> </subject> <authoredOn value="2015-01-15"/> <requester> <!-- Linked to the practitioner who treats patient --> <reference value="Practitioner/f007"/> <display value="Patrick Pump"/> </requester> <reasonCode> <coding> <system value="http://snomed.info/sct"/> <code value="92818009"/> <display value="Chronic myeloid Leukemia (disorder)"/> </coding> </reasonCode> <dosageInstruction> <sequence value="1"/> <text value="6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL"/> <timing> <repeat> <frequency value="1"/> <period value="1"/> <periodUnit value="d"/> </repeat> </timing> <route> <coding> <system value="http://snomed.info/sct"/> <code value="26643006"/> <display value="Oral route (qualifier value)"/> </coding> </route> <doseAndRate> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/> <code value="ordered"/> <display value="Ordered"/> </coding> </type> <doseQuantity> <value value="6"/> <unit value="mg"/> <system value="http://unitsofmeasure.org"/> <code value="mg"/> </doseQuantity> </doseAndRate> </dosageInstruction> </MedicationRequest>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.